Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
9,424,823
-
Shares change
-
-386,856
-
Total reported value, excl. options
-
$30,911,164
-
Value change
-
-$5,403,616
-
Number of buys
-
30
-
Number of sells
-
-20
-
Price
-
$3.28
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q3 2019
64 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q3 2019.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,424,823 shares
.
Largest 10 shareholders include FMR LLC (2,811,434 shares), Bellevue Group AG (1,230,523 shares), Cormorant Asset Management, LP (927,869 shares), BlackRock Inc. (898,914 shares), FRAZIER MANAGEMENT LLC (467,743 shares), VICTORY CAPITAL MANAGEMENT INC (461,571 shares), VANGUARD GROUP INC (372,228 shares), FRANKLIN RESOURCES INC (326,900 shares), STATE STREET CORP (232,714 shares), and NORTHERN TRUST CORP (152,414 shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.